Beranda › Atrofi Otot Tulang Belakang › Texas › Lewisville
Uji klinis Atrofi Otot Tulang Belakang di Lewisville, TX
4 studi untuk Atrofi Otot Tulang Belakang mencari peserta di lokasi sekitar Lewisville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
Menerima pesertaFase 2
- Neurology Rare Disease Center, Flower Mound · 6 mi jauhnya
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Menerima pesertaFase 2
- Neurology Rare Disease Center, Flower Mound · 6 mi jauhnya
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Menerima pesertaFase 3
- Neurology Rare Disease Center, Flower Mound · 6 mi jauhnya
A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
Menerima pesertaFase 3
- Neurology Rare Disease Center, Flower Mound · 6 mi jauhnya
Uji klinis Atrofi Otot Tulang Belakang di kota lain
- New York City, NY9 studi
- Mountain View, CA9 studi
- Philadelphia, PA7 studi
- Grand Rapids, MI6 studi
- Chicago, IL6 studi
- Norfolk, VA6 studi
- Houston, TX5 studi
- Boston, MA5 studi
- Phoenix, AZ4 studi
- Little Rock, AR4 studi
- Aurora, CO4 studi
- Memphis, TN3 studi
Studi lain di Lewisville
- Kolitis Ulseratif10 studi
- Penyakit Crohn9 studi
- Diabetes Tipe 25 studi
- Kanker Payudara5 studi
- Penyakit Radang Usus4 studi
- Penyakit Pencernaan4 studi
- Degenerasi Makula3 studi
- Penyakit Kardiovaskular3 studi
- Kanker Kolorektal3 studi
- Atrofi Geografis3 studi
- Kanker Payudara Triple-Negatif3 studi
- Penyakit Paru3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.